With its serverless infrastructure, Tensorlake makes it simpler to deploy and scale agentic workflows - SiliconANGLE ...

MSFT's Azure AI momentum builds as cloud revenues jump 39%, Copilot adoption surges and new AI tools expand enterprise demand even as capacity constraints persist.

Intervertebral disc degeneration (IVDD) constitutes a major source of chronic low back pain and functional limitation worldwide, substantially impairing physical activity, sports performance, and ...

The pace of innovation in cloud computing continues unabated, with AWS recently unveiling durable functions for AWS Lambda. This move could have significant implications for how enterprises design and ...

Explore 20 different activation functions for deep neural networks, with Python examples including ELU, ReLU, Leaky-ReLU, Sigmoid, and more. #ActivationFunctions #DeepLearning #Python Teens arrested ...

While autologous CAR T-cell therapies have revolutionized the treatment of hematologic malignancies, their widespread application is hindered by manufacturing complexities, high costs, and limited ...

Cloud security architect and advisor Steven Smiley walked attendees through a slate of notable AWS announcements in a Virtualization & Cloud Review webcast today. The presentation held by Smiley, an ...

When you pick up a prescription—perhaps a medication to manage a chronic illness or one to ease a loved one’s pain—you trust that the treatment is both safe and will do what it promises. This ...

I am a Backend Developer and Software Engineer with a solid background in Artificial Intelligence in academic and professional fields, looking forwa ...

– Initial Results from Kite-753, Optimized with Novel Manufacturing Process That Preserves T-Cell Fitness, Show High Complete Response Rate and Favorable Safety Trend – – Novel Construct for Two ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV) ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced ...